The encouraged generic drugs selected by Chinese authorities can benefit from preferential policy support in terms of review and approval, clinical trials and critical generic technology researches.
131 results
Log in to view more data, Log in now
| SN | Drug Name | Dosage Form | Strength | Source |
| 3-26 | view | Tablet |
20 mg
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-27 | view | Extended-release Injection |
3 ml: 0.6 g
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-28 | view | Inhalation Solution |
3 ml: 0.175 mg
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-29 | view | Chewable Tablet |
40 mg
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-29 | view | Chewable Tablet |
20 mg
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-29 | view | Chewable Tablet |
10 mg
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-29 | view | Capsule |
40 mg
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-29 | view | Capsule |
20 mg
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-29 | view | Capsule |
10 mg
|
The 3rd Batch of Encouraged Generic Drugs |
| 3-30 | view | Tablet |
41.5 mg: 40mg relugolix, 1 mg estradiol, and 0.5 mg norethindrone
|
The 3rd Batch of Encouraged Generic Drugs |